Serious adverse effects that require monitoring include but are not limited to:

**Agranulocytosis**

Weekly complete blood count (CBC) to measure ANC levels. ANC levels less than 1500/mm indicate neutropenia. Levels less than 500/mm indicate agranulocytosis.

**Metabolic Syndrome**

Diet and exercise, blood glucose levels

**Cardiovascular**

Baseline troponin I or T levels, high sensitivity CRP levels, echocardiography, and BNP levels, as well as vitals and weekly laboratory testing of troponins, CRP, and BNP levels

**Seizure**

EEG and clozapine blood levels